About
Pharmaceutical manufacturing for hospital market, private market, and renal care
Areas of Focus
Categories
Small Molecule PharmaceuticalOther European
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
0
As Collaborator
6
Total Enrollment
672
By Phase
PHASE1: 2PHASE1/PHASE2: 1PHASE2: 1PHASE4: 2
By Status
COMPLETED: 2UNKNOWN: 2WITHDRAWN: 1TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05855187Collaborator
Bioequivalence Study of Modafinil From Bravamax 200 mg Scored Tablets (Chemipharm Pharmaceutical Industries, Egypt) Versus Vigil 200 mg Tablets (Teva GmbH, Germany)
PHASE1Completed
30 participants
Started: Nov 15, 2022 · Completed: Jan 10, 2023
NCT04731051Collaborator
The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients
PHASE1/PHASE2Withdrawn
Started: Oct 31, 2022 · Completed: Dec 31, 2022
NCT05113810Collaborator
The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19
PHASE2Unknown
110 participants
Started: Mar 20, 2022 · Completed: Jul 20, 2022
NCT05184491Collaborator
Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management
PHASE4Unknown
500 participants
Started: Oct 15, 2021 · Completed: Mar 15, 2022
NCT05038969Collaborator
Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Pharmaceuticals Industries, Egypt) and Nexium 40 mg Delayed Release Capsules (AstraZeneca Sweden, Product of France)
PHASE1Completed
30 participants
Started: Mar 18, 2021 · Completed: May 28, 2021
Locations (1)
Headquarters
Athens, Greece
Map
Loading map...